methylprednisolone has been researched along with dextromethorphan in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Erol, FS; Ilhan, N; Ozveren, MF; Topsakal, C; Yilmaz, N | 1 |
| Fu, B; Lei, H; Wang, J; Zhang, J; Zhao, Y; Zhu, G | 1 |
1 review(s) available for methylprednisolone and dextromethorphan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for methylprednisolone and dextromethorphan
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury.
Topics: Animals; Dextromethorphan; Drug Combinations; Erythrocytes; Excitatory Amino Acid Antagonists; Glutathione Peroxidase; Lipid Peroxides; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord Injuries; Superoxide Dismutase | 2002 |
Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
Topics: Adult; Autoantibodies; Dextromethorphan; Drug Interactions; Female; Humans; Injections, Spinal; Lupus Vasculitis, Central Nervous System; Methotrexate; Methylprednisolone; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2014 |